{
  "disease_name": "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
  "orpha_code": "415",
  "drugs": [
    {
      "name": "RAVICTI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/445606?name=415&mode=orpha&region=",
      "regulatory_id": "445606",
      "orpha_substance_code": "ORPHA:247525",
      "details": [
        "RAVICTI(Tradename                        - 27/11/2015)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "RAVICTI(Tradename                        - 27/11/2015)",
        "(Tradename                        - 27/11/2015)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/445605?name=415&mode=orpha&region=&status=all",
          "text": "RAVICTI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90",
          "text": "ORPHA:90 Argininemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247525",
          "text": "ORPHA:247525 Citrullinemia type I",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/445606?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:247525 Citrullinemia type I\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Sodium benzoate",
      "substance_url": "/en/drug/substance/83694?name=415&mode=orpha&region=&status=all",
      "substance_id": "83694",
      "regulatory_url": "/en/drug/regulatory/480444?name=415&mode=orpha&region=",
      "regulatory_id": "480444",
      "orpha_substance_code": "ORPHA:415",
      "details": [
        "Sodium benzoate(Medicinal product                        - 29/08/2016)Disease(s) concernedORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
        "Sodium benzoate(Medicinal product                        - 29/08/2016)",
        "(Medicinal product                        - 29/08/2016)",
        "Disease(s) concernedORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/83694?name=415&mode=orpha&region=&status=all",
          "text": "Sodium benzoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480444?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Heterologous human adult liver-derived progenitor cells",
      "substance_url": "/en/drug/substance/356372?name=415&mode=orpha&region=&status=all",
      "substance_id": "356372",
      "regulatory_url": "/en/drug/regulatory/364080?name=415&mode=orpha&region=",
      "regulatory_id": "364080",
      "orpha_substance_code": "ORPHA:415",
      "details": [
        "Heterologous human adult liver-derived progenitor cells(Medicinal product                        - 17/07/2013)Disease(s) concernedORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
        "Heterologous human adult liver-derived progenitor cells(Medicinal product                        - 17/07/2013)",
        "(Medicinal product                        - 17/07/2013)",
        "Disease(s) concernedORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/356372?name=415&mode=orpha&region=&status=all",
          "text": "Heterologous human adult liver-derived progenitor cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/364080?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Glycerol phenylbutyrate",
      "substance_url": "/en/drug/substance/222387?name=415&mode=orpha&region=&status=all",
      "substance_id": "222387",
      "regulatory_url": "/en/drug/regulatory/238152?name=415&mode=orpha&region=",
      "regulatory_id": "238152",
      "orpha_substance_code": "ORPHA:415",
      "details": [
        "Glycerol phenylbutyrate(Medicinal product                        - 10/06/2010)Disease(s) concernedORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
        "Glycerol phenylbutyrate(Medicinal product                        - 10/06/2010)",
        "(Medicinal product                        - 10/06/2010)",
        "Disease(s) concernedORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/222387?name=415&mode=orpha&region=&status=all",
          "text": "Glycerol phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/238152?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "RAVICTI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/465104?name=415&mode=orpha&region=",
      "regulatory_id": "465104",
      "orpha_substance_code": "ORPHA:247525",
      "details": [
        "RAVICTI(Tradename                        - 01/02/2013)Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "RAVICTI(Tradename                        - 01/02/2013)",
        "(Tradename                        - 01/02/2013)",
        "Disease(s) concernedORPHA:664 Ornithine transcarbamylase deficiencyORPHA:90 ArgininemiaORPHA:23 Argininosuccinic aciduriaORPHA:147 Carbamoyl-phosphate synthetase 1 deficiencyORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndromeORPHA:247525 Citrullinemia type I",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/445605?name=415&mode=orpha&region=&status=all",
          "text": "RAVICTI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/664",
          "text": "ORPHA:664 Ornithine transcarbamylase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90",
          "text": "ORPHA:90 Argininemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/23",
          "text": "ORPHA:23 Argininosuccinic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/147",
          "text": "ORPHA:147 Carbamoyl-phosphate synthetase 1 deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/415",
          "text": "ORPHA:415 Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/247525",
          "text": "ORPHA:247525 Citrullinemia type I",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/465104?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:247525 Citrullinemia type I\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Allogeneic adult liver-derived stem cells",
      "substance_url": "/en/drug/substance/629851?name=415&mode=orpha&region=&status=all",
      "substance_id": "629851",
      "regulatory_url": "/en/drug/regulatory/629852?name=415&mode=orpha&region=",
      "regulatory_id": "629852",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Allogeneic adult liver-derived stem cells(Medicinal product                        - 10/08/2022)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Allogeneic adult liver-derived stem cells(Medicinal product                        - 10/08/2022)",
        "(Medicinal product                        - 10/08/2022)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/629851?name=415&mode=orpha&region=&status=all",
          "text": "Allogeneic adult liver-derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/629852?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end",
      "substance_url": "/en/drug/substance/688360?name=415&mode=orpha&region=&status=all",
      "substance_id": "688360",
      "regulatory_url": "/en/drug/regulatory/688517?name=415&mode=orpha&region=",
      "regulatory_id": "688517",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end(Medicinal product                        - 11/09/2024)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end(Medicinal product                        - 11/09/2024)",
        "(Medicinal product                        - 11/09/2024)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/688360?name=415&mode=orpha&region=&status=all",
          "text": "Single strand 20-mer antisense oligonucleotide (ASO) targeting a CPS1 regulatory RNA with a triantennary N-acetylgalactosamine (GalNAc) ligand attached at the 3' end",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/688517?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Glycerol phenylbutyrate",
      "substance_url": "/en/drug/substance/222387?name=415&mode=orpha&region=&status=all",
      "substance_id": "222387",
      "regulatory_url": "/en/drug/regulatory/238146?name=415&mode=orpha&region=",
      "regulatory_id": "238146",
      "orpha_substance_code": "ORPHA:79167",
      "details": [
        "Glycerol phenylbutyrate(Medicinal product                        - 27/04/2009)Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "Glycerol phenylbutyrate(Medicinal product                        - 27/04/2009)",
        "(Medicinal product                        - 27/04/2009)",
        "Disease(s) concernedORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/222387?name=415&mode=orpha&region=&status=all",
          "text": "Glycerol phenylbutyrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79167",
          "text": "ORPHA:79167 Disorder of urea cycle metabolism and ammonia detoxification",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/238146?name=415&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "of urea cycle metabolism and ammonia detoxification\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:00:32.065290",
  "run_number": 1,
  "total_drugs_found": 8,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Hyperornithinemia-hyperammonemia-homocitrullinuria+syndrome&orphaCode=415&name=415&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome",
    "orphaCode": "415",
    "name": "415",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}